Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Renal papillary necrosis epidemiology and demographics
Introduction
Overview
Overview
The prevalence and demographic characteristics of renal papillary necrosis depend on the causative agent.
Epidemiology and Demographics
Epidemiology and Demographics
Prevalence
- Renal papillary necrosis due to analgesic abuse is more prevalent in Australia and England and less in the US. [1]
- In Australia, the prevalence of renal papillary necrosis ranges from 15000 per 100,000 persons to 20000 per 100,000 persons requiring kidney transplant. [1]
- The prevalence of renal papillary necrosis was reported 65,000 per 100,000 patients with sickle cell disease. [2]
- In Africa, the prevalence of symptomatic renal papillary necrosis was reported 2300 per 100,000 patients with sickle cell disease with homozygous S. [3]
Incidence
- In developing countries, the incidence of renal papillary necrosis is 3900 per 100,000 persons.[4]
- The incidence of renal papillary necrosis is 30,000 to 40,000 per 100,000 patients with Sickle cell disease. [5]
Age
- The prevalence of renal papillary necrosis increases with age. It commonly affects the elderly (>60 years). “Renal Papillary Necrosis – American Urological Association”.
- Renal papillary necrosis due to sickle cell disease commonly affects adults in the third and fourth decades.[6]
Gender
- Renal papillary necrosis is more prevalent in women.[1][3]
Race
References
References
- ↑ 1.0 1.1 1.2 Brix AE (2002). “Renal papillary necrosis”. Toxicol Pathol. 30 (6): 672–4. doi:10.1080/01926230290166760. PMID 12512867.
- ↑ Pandya KK, Koshy M, Brown N, Presman D (1976). “Renal papillary necrosis in sickle cell hemoglobinopathies”. J Urol. 115 (5): 497–501. doi:10.1016/s0022-5347(17)59255-1. PMID 1271537.
- ↑ 3.0 3.1 Madu AJ, Okoye AE, Ajuba IC, Madu KA, Anigbo C, Agu K (2016). “Prevalence and associations of symptomatic renal papillary necrosis in sickle cell anemia patients in South-Eastern Nigeria”. Niger J Clin Pract. 19 (4): 471–4. doi:10.4103/1119-3077.183299. PMID 27251962.
- ↑ Dahniya MH, Szmigielski W, Reddy CK, Hanna RM, Cherian MJ, Mattar MS; et al. (1992). “Renal papillary necrosis in Kuwait”. Trop Geogr Med. 44 (4): 331–7. PMID 1295143.
- ↑ Alhwiesh A (2014). “An update on sickle cell nephropathy”. Saudi J Kidney Dis Transpl. 25 (2): 249–65. doi:10.4103/1319-2442.128495. PMID 24625990.
- ↑ Henderickx MMEL, Brits T, De Baets K, Seghers M, Maes P, Trouet D; et al. (2017). “Renal papillary necrosis in patients with sickle cell disease: How to recognize this ‘forgotten’ diagnosis”. J Pediatr Urol. 13 (3): 250–256. doi:10.1016/j.jpurol.2017.01.020. PMID 28341428.
Editor-In-Chief: Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]